New Arrival - Creatine for women. Shop now!
Iron deficiency affects millions worldwide, yet many aren't aware that common heartburn medications could be contributing to this problem.
Jump to:
Iron deficiency affects millions worldwide, yet many aren't aware that common heartburn medications could be contributing to this problem. This blog explores the relationship between proton pump inhibitors (PPIs) like Nexium and acid neutralisers like Gaviscon and their potential impact on iron absorption.
Your stomach is naturally acidic for good reason. This acidic environment serves several crucial functions, including:
When it comes to iron specifically, stomach acid plays an essential role. Iron exists in two primary forms in our diet: heme iron (found in animal products) and non-heme iron (found in plant foods). Non-heme iron, which makes up the majority of dietary iron for many people, is particularly dependent on stomach acid for absorption.
Stomach acid converts non-heme iron from its ferric (Fe³⁺) form to the ferrous (Fe²⁺) form, which is much more readily absorbed in the small intestine. When stomach acid is reduced, this conversion process is impaired, potentially leading to decreased iron absorption over time.
Proton pump inhibitors (PPIs) like Nexium (esomeprazole) work by blocking the enzyme system responsible for producing stomach acid. They're among the most potent acid-reducing medications available and can reduce stomach acid production by up to 99%.
Antacids like Gaviscon work differently—they neutralize existing stomach acid rather than preventing its production. While their effect is more temporary than PPIs, regular use can still maintain a less acidic stomach environment.
Multiple studies have established a relationship between long-term PPI use and iron deficiency:
A 2015 study published in the Journal of Clinical Gastroenterology found that PPI users had significantly lower ferritin levels (an indicator of iron stores) compared to non-users.
A 2017 systematic review in the Journal of Clinical Pharmacy and Therapeutics concluded that PPI therapy was associated with a decreased absorption of non-heme iron, potentially leading to iron deficiency anemia in vulnerable populations.
Research suggests that the risk increases with:
Iron deficiency develops gradually, and symptoms may not appear until iron stores are significantly depleted. Common signs include:
If you require long-term acid-reducing medication, consider these strategies to maintain healthy iron levels:
Consult your healthcare provider if you:
While acid-reducing medications are invaluable for managing conditions like GERD, peptic ulcers, and chronic heartburn, their potential impact on nutrient absorption—particularly iron—shouldn't be overlooked. By understanding this connection and taking proactive steps, you can manage your digestive symptoms while protecting your iron status and overall health.
Remember that both untreated acid reflux and iron deficiency can have serious health consequences, so always work with your healthcare provider to find the optimal approach for your individual needs.